Institute of Graduate Education

Academic Members

Faculty Member, PhD Orçun Can

Faculty Member, PhD
Orçun Can

Tıbbi Onkoloji (İç Hastalıkları)

He was born in Adana in 1985. He completed his secondary education at Adana Kurttepe Anatolian High School, Mersin Science High School, and Adana Bilimkent High School. He completed his medical education at Çukurova University Faculty of Medicine in 2009. He completed his Internal Medicine residency at Istanbul Medeniyet University Göztepe Training and Research Hospital between 2009-2014. He did his compulsory internal medicine service at Kırklareli Pınarhisar State Hospital. He completed his medical oncology subspecialty in Health Sciences University Okmeydanı Training and Research Hospital, medical oncology department in 2015-2018. He received training on multidisciplinary treatment in metastatic colorectal cancer from Professor Dr. J. Kerr at Oxford University in 2015. He also received training on the interdisciplinary management of metastatic colorectal and lung cancers from Prof. Dr. Claus-Henning Köhne and Prof. Dr. Frank Griesinger at the Oldenburg Clinic in Germany in 2017. He did medical oncology sub-branch compulsory service at Nevşehir State Hospital and Istanbul Prof. Dr. Cemil Taşçıoğlu City Hospital. Breast cancer, lung cancer, colorectal cancers, stomach cancer, head and neck cancers, gynecological cancers, sarcomas, targeted therapies and immunotherapy, and molecular oncology are his main areas of interest. He has articles published in domestic and international journals. He is married and has a son.

Araştırma Alanları

  • Breast Cancer
  • Cancer Biology
  • Cancers of Gastrointestinal Tract
  • Cancer Treatment
  • Anticancer agents
  • Immunotherapy
  • prostate cancer
  • Gynecological Oncology
  • Anticancer Drug Development

Çalışma Alanları

  • Sağlık Bilimleri Temel Alanı
  • Tıbbi Onkoloji (İç Hastalıkları)
  • How reliable is the high-volume definition in prostate cancer patients: the potential game-changing role of PSMA, 2023
  • Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium, 2023
  • Serum fetuin-A and RANKL levels in patients with early stage breast cancer, 2023
  • External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database, 2023
  • Küçük Hücreli Akciğer Kanserinde İmmünoterapi, 2023
  • Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study, 2022
  • The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors, 2022
  • Efect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study, 2022
  • The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study, 2022
  • Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database, 2021
  • Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study, 2021
  • Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer, 2021
  • Arrhythmogenic Right Ventricular Cardiomyopathy in a Patient Wıth Von Hippel Lindau Disease , 2021
  • Mirror aneurysm of ICA terminus associated with adult polycystic kidney disease, 2021
  • The effects of fulvestrant treatment on hormone receptor-positive metastatic breast cancer, 2020
  • Adrenocortical Carcinoma: Single Center Experience, 2020
  • Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study, 2020
  • The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer, 2020
  • Non-urothelial Bladder Cancers: Single Center Experience, 2019
  • Factors Affecting Disease-Free Survival in Operated Nonmetastatic Gastrointestinal Stromal Tumors, 2019
  • Metastatik Pankreas Kanserli Hastalarda FOLFİRİNOX Rejiminin Etkinlik ve Tolerabilitesi, 2018
  • Prognostic significance of primary tumor localization in stage II and III colon cancer, 2018
  • Factors Affecting Survival in Neuroendocrine Tumors: A 15-Year Single Center Experience, 2018
  • Triglyceride Response to Oral Glucose Load: Is it Exaggerated in Metabolic Syndrome?, 2016
  • Fulvestrant efficacy in artificial menopausal hormone receptor positive and HER 2 negative metastatic breast cancer patients under 50 years old, 2018
  • The Impact of Non-Cardiac Surgery on Electrocardiograph Changes, Troponin Levels in patients with Intermediate and High Risk According to Framingham General Cardiovascular Disease Risk Score, 2013
  • Yaşlı lokal ileri mide kanseri hastalarında perioperatif Fluorourasil-Lökoverin-Oksaliplatin-Dosetaksel bazlı tedavi etkinliği ve güvenliği , 2021
  • Efficacy Of Folfirinox In Advanced Age Patients With Metastatic Pancreatic Cancer , 2020
  • Metastatik Renal Hücreli Kanserde Nivolumab Tedavisi Sonuçları; Tek Merkez Deneyimi, 2020
  • Extensive Stage Küçük Hücreli Akciğer Kanserinde Sağkalım ve Sağkalımı Etkileyen Prognostik Faktörlerin Değerlendirilmesi, 2022
  • The Management Of Heart Failure In Internal Medicine Clinics: Should It Be Revised?, 2019
  • Gastroenteropancreatic neuroendocrinecarcinoma: single center experience, 2020
  • Pankreas tümörlerinde nadir bir alt grup: Pankreatik liposarkom olgusu, 2022
  • Nadir ve zorlu bir alt grup: Küçük Hücreli Mesane Kanserinde Tek Merkez Deneyimi, 2021
  • The attrition of patients with metastatic renal cell carcinoma across treatment lines: A real-life experience from the Turkish oncology group kidney cancer consortium (TKCC) database, 2021
  • Current Immunotherapy Landscape for Solid Tumors, ISBN: 978-625-395-244-0, 2024
  • ENDEKS TÜRÜ GÜNCELLENECEK---------Kanser Hastalarının Başvurduğu Geleneksel veTamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim, ISBN: 978-625-399-694-9, 2024
  • Hedefe Yönelik Ajanların İlaç Etkileşimleri ve Yan Etkileri - 2021, ISBN: 978-625-401-466-6, 2021
  • Klinik Çalışmalarla Onkolojide Hedefli Tedaviler, ISBN: 978-605-281-585-4, 2019
  • Klinik Çalışmalarla Onkolojide Hedefli Tedaviler, ISBN: 978-605-281-585-4, 2019